| 2024-01-30 | Allogene Therapeutics, Inc. ALLO | CHIEF FINANCIAL OFFICER | 190 0.0001% | $3.60 | $683 | -2.34% | ||
| 2023-06-13 | Perrigo Company plc PRGO | director | 10,000 0.0074% | $33.06 | $330,637 | -4.62% | ||
| 2023-03-06 | Perrigo Company plc PRGO | director | 5,000 0.0038% | $38.05 | $190,270 | -8.74% | ||
| 2021-12-16 | Perrigo Company plc PRGO | director | 10,000 0.0075% | $36.85 | $368,540 | +4.8% | ||
| 2021-03-17 | Perrigo Company plc PRGO | director | 5,000 0.0037% | $41.29 | $206,436 | +2.17% | ||
| 2018-11-12 | Perrigo Company plc PRGO | director | 3,000 0.0022% | $65.35 | $196,058 | -23.91% | ||
| 2016-12-09 | Viracta Therapeutics, Inc. VIRX | director | 594 0.0038% | $3.90 | $2,318 | -22.08% | ||
| 2016-12-08 | Viracta Therapeutics, Inc. VIRX | director | 3,146 0.0201% | $3.87 | $12,159 | -21.76% | ||
| 2016-11-21 | Perrigo Company plc PRGO | director | 2,500 0.0017% | $88.75 | $221,875 | -13.64% | ||
| 2016-05-26 | Viracta Therapeutics, Inc. VIRX | director | 9,500 0.0109% | $0.47 | $4,455 | +40.43% | ||
| 2016-05-25 | Viracta Therapeutics, Inc. VIRX | director | 22,505 0.0255% | $0.49 | $10,933 | +34.69% | ||
| 2016-05-24 | Viracta Therapeutics, Inc. VIRX | director | 30,000 0.0333% | $0.46 | $13,881 | +37.5% |